Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Nieuwdorp

Showing results (281-290 of 416) with videos related to

Pageof 42
Sort By:
Obesity Science & Practice|June 12, 2020
Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistanceAnnick V Hartstra, Pieter F de Groot, Diogo Mendes Bastos, et al.
Journal of Diabetes and Its Complications|January 24, 2022
Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trialsAnne C Hesp, Mark M Smits, Erik J M van Bommel, et al.
Thyroid : Official Journal of the American Thyroid Association|November 27, 2023
Comparative Analysis of Taxonomic and Functional Gut Microbiota Profiles in Relation to Seroconversion of Thyroid Peroxidase Antibodies in Euthyroid ParticipantsAline C Fenneman, Ulrika Boulund, Didier Collard, et al.
BMJ Open|January 9, 2025
Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitisQuinten J J Augustijn, Aldo Grefhorst, Pleun de Groen, et al.
Gut Microbes|February 7, 2022
Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgeryTorsten P M Scheithauer, Mark Davids, Maaike Winkelmeijer, et al.
Diabetologia|July 8, 2022
Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetesJayron J Habibe, Maria P Clemente-Olivo, Torsten P M Scheithauer, et al.
Diabetes, Obesity & Metabolism|June 10, 2018
Iloprost infusion prevents the insulin-induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patientsAnna L Emanuel, Nicolien C de Clercq, Annefleur M Koopen, et al.
Journal of Lipid Research|June 22, 2025
Non-invasive identification of steatohepatitis in patients with MASLD using a sterol and lipidomic signatureRatna Budhi Pebriana, Ting Chen, Rico J E Derks, et al.
European Heart Journal|September 2, 2020
Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS studyBarbara J H Verhaar, Didier Collard, Andrei Prodan, et al.
Journal of Hypertension|June 10, 2020
Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetesErik J M van Bommel, Mark M Smits, Danique Ruiter, et al.
Pageof 42

Showing results (281-290 of 416) with videos related to

Sort By:
Pageof 42
Obesity Science & Practice|June 12, 2020
Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistanceAnnick V Hartstra, Pieter F de Groot, Diogo Mendes Bastos, et al.
Journal of Diabetes and Its Complications|January 24, 2022
Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trialsAnne C Hesp, Mark M Smits, Erik J M van Bommel, et al.
Thyroid : Official Journal of the American Thyroid Association|November 27, 2023
Comparative Analysis of Taxonomic and Functional Gut Microbiota Profiles in Relation to Seroconversion of Thyroid Peroxidase Antibodies in Euthyroid ParticipantsAline C Fenneman, Ulrika Boulund, Didier Collard, et al.
BMJ Open|January 9, 2025
Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitisQuinten J J Augustijn, Aldo Grefhorst, Pleun de Groen, et al.
Gut Microbes|February 7, 2022
Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgeryTorsten P M Scheithauer, Mark Davids, Maaike Winkelmeijer, et al.
Diabetologia|July 8, 2022
Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetesJayron J Habibe, Maria P Clemente-Olivo, Torsten P M Scheithauer, et al.
Diabetes, Obesity & Metabolism|June 10, 2018
Iloprost infusion prevents the insulin-induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patientsAnna L Emanuel, Nicolien C de Clercq, Annefleur M Koopen, et al.
Journal of Lipid Research|June 22, 2025
Non-invasive identification of steatohepatitis in patients with MASLD using a sterol and lipidomic signatureRatna Budhi Pebriana, Ting Chen, Rico J E Derks, et al.
European Heart Journal|September 2, 2020
Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS studyBarbara J H Verhaar, Didier Collard, Andrei Prodan, et al.
Journal of Hypertension|June 10, 2020
Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetesErik J M van Bommel, Mark M Smits, Danique Ruiter, et al.
Pageof 42